Evidence map›Paper›PMID 36373145›Full record

ArticleBuilding simulation2023

Occupancy-aided ventilation for airborne infection risk control: Continuously or intermittently reduced occupancies?

Sheng Zhang, Dun Niu, Zhang Lin

Abstract read
In one paragraph

Article in Building simulation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Safe COBuilding and environment · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sheng ZhangSchool of Human Settlements and Civil Engineering, Xi'an Jiaotong University, Xi'an, China.
Dun NiuSchool of Human Settlements and Civil Engineering, Xi'an Jiaotong University, Xi'an, China.
Zhang LinDivision of Building Science and Technology, City University of Hong Kong, Hong Kong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ventilation is an important engineering measure to control the airborne infection risk of acute respiratory diseases, e.g., Corona Virus Disease 2019 (COVID-19). Occupancy-aided ventilation methods can effectively improve the airborne infection risk control performance with a sacrifice of decreasing working productivity because of the reduced occupancy. This study evaluates the effectiveness of two occupancy-aided ventilation methods, i.e., the continuously reduced occupancy method and the intermittently reduced occupancy method. The continuously reduced occupancy method is determined by the steady equation of the mass conservation law of the indoor contaminant, and the intermittently reduced occupancy method is determined by a genetic algorithm-based optimization. A two-scenarios-based evaluation framework is developed, i.e., one with targeted airborne infection risk control performance (indicated by the mean rebreathed fraction) and the other with targeted working productivity (indicated by the accumulated occupancy). The results show that the improvement in the airborne infection risk control performance linearly and quadratically increases with the reduction in the working productivity for the continuously reduced occupancy method and the intermittently reduced occupancy method respectively. At a given targeted airborne infection risk control performance, the intermittently reduced occupancy method outperforms the continuously reduced occupancy method by improving the working productivity by up to 92%. At a given targeted working productivity, the intermittently reduced occupancy method outperforms the continuously reduced occupancy method by improving the airborne infection risk control performance by up to 38%.

Indexed as

airborne infection riskcontinuously reduced occupancyintermittently reduced occupancyoccupancy-aided ventilationrebreathed fractionworking productivity

Identifiers

PMID36373145
PMCPMC9638348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.